20 May 2022 --- Daily consumption of oral cannabidiol (CBD) has a strong safety profile, an industry-backed study has revealed. The findings set to be presented to the US Food and Drug Administration (FDA) aim to minimize the agency’s safety concerns surrounding CBD and pave the way for regulation.